U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Dec-22-2023 | CANCELLED SECTION 71 | C71TO | |
Jul-28-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Jul-07-2017 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Jul-07-2017 | FINAL DISPOSITION PROCESSED | FIMPP | |
Jul-06-2017 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jun-06-2017 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Mar-21-2017 | PUBLISHED FOR OPPOSITION | PUBOA | |
Mar-17-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Mar-01-2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Mar-01-2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Mar-01-2017 | NOTICE OF PUBLICATION | NPUBO | |
Feb-08-2017 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Feb-08-2017 | ASSIGNED TO EXAMINER | DOCKD | |
Jan-21-2017 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Jan-17-2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Jan-13-2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Jan-05-2017 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM |